logo
Select company
Select metric
4Current Ratio
VS
Market
78
Sector
57
Industry
43
History
7
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

YMAB

Company Name

Y-MABS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Y-MABS THERAPEUTICS INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

YMAB - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 91.79M4$ 22.95M
3/31/2025$ 90.45M4.77$ 18.96M
12/31/2024$ 98.51M4.16$ 23.7M
9/30/2024$ 99.06M3.92$ 25.29M
6/30/2024$ 126.76M2.92$ 43.47M
3/31/2024$ 108.27M6.15$ 17.61M
12/31/2023$ 111.11M5.52$ 20.13M
9/30/2023$ 114.86M5.27$ 21.81M
6/30/2023$ 115.78M4.78$ 24.23M
3/31/2023$ 124.01M4.78$ 25.92M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • Y-MABS THERAPEUTICS INC's latest trailing twelve months (TTM) Current Ratio stands at 6.74.
  • Over the past 5 years, Y-MABS THERAPEUTICS INC's average Current Ratio has been 6.16.
  • The median Current Ratio for Y-MABS THERAPEUTICS INC during this period was 5.25
  • Y-MABS THERAPEUTICS INC reached its highest Current Ratio over the past 5 years at 15.53.
  • The lowest Current Ratio recorded by Y-MABS THERAPEUTICS INC in the same timeframe 2.92

Y-MABS THERAPEUTICS INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
ADCT : ADC THERAPEUTICS SA 4.93NKTR : NEKTAR THERAPEUTICS 2.61KURA : KURA ONCOLOGY INC 6.16LXRX : LEXICON PHARMACEUTICALS INC 4.16TRDA : ENTRADA THERAPEUTICS INC 18.64XOMA : XOMA ROYALTY CORP 4.88SAGE : SAGE THERAPEUTICS INC 9.16CDXS : CODEXIS INC 5.82ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC 5.9SGMO : SANGAMO THERAPEUTICS INC 1.05

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for Y-MABS THERAPEUTICS INC is calculated as follows: AssetsC [ $ 133.21M ] / LiabilitesC [ $ 19.78M ]
(=) Current Ratio [ 6.74 ]

YMAB - Current Ratio, Last 5 years

2.92

Minimum

Jun 30, 2024

15.53

Maximum

Mar 31, 2021

6.16

Average

5.25

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44